I've thought that for about three months. They have been tightening up PRs and letting the medical guys handle most of the CCs but the handling of 13D group was off the charts. It was the most Big Pharma move I've ever seem from management. They actually look like they know how to play with the big boys. And I think you are exactly right about some new advisor.